Drug comparisons
Tirzepatide vs Insulin Glulisine Human
Compare Tirzepatide (Mounjaro) vs Insulin Glulisine (Apidra) for T2 diabetes. Dual GIP/GLP-1 vs rapid insulin: A1C, weight loss vs gain, hypo risks.
No comparison dimensions are available for this page.
Clinical context
Type 2 diabetes patients comparing weekly dual incretin agonist tirzepatide against rapid-acting insulin glulisine for control and weight.
Bottom line
Tirzepatide typically outperforms insulin glulisine in A1C and weight loss for T2D but insulin remains essential for some patients.
All medication comparisons